Quantcast

Latest treatment of multiple sclerosis Stories

2015-05-07 08:32:38

Long term clinical trials will increase likelihood of prescriptions receiving approval and adoption by physicians, finds Frost & Sullivan MOUNTAIN VIEW, Calif., May 7, 2015 /PRNewswire/ --

2015-04-23 12:31:03

Interim Results Indicate Positive Efficacy Trends in FDA-Approved Phase I Clinical Stem Cell Trial For Patients with Multiple Sclerosis NEW YORK, April 23, 2015 /PRNewswire/ -- Tisch

2015-04-16 08:33:09

- Data analyses in relapsing MS highlight MRI outcomes and 'no evident disease activity' (NEDA) measure for Rebif® (interferon beta-1a) vs.

2014-06-26 12:29:42

LONDON, June 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

2014-06-25 12:30:05

MISSISSAUGA, ON, June 25, 2014 /CNW/ - Biogen Idec Canada announces today that TECFIDERA(TM) (dimethyl fumarate) is now available for reimbursement in British Columbia (B.C.) through B.C.

2014-06-12 12:30:07

Current Neurologist-Reported Patient Share for Tecfidera Exceeds that of Genzyme's Aubagio and Novartis's Gilenya Combined, According to Findings from Decision Resources Group BURLINGTON, Mass.,

2014-05-27 08:28:11

NESS ZIONA, Israel, May 27, 2014 /PRNewswire/ -- Mapi Pharma Ltd.


Word of the Day
overword
  • To say in too many words; to express verbosely.
  • To express in too many words: sometimes used reflexively.
  • The leading idea or a repeated phrase, as of a song or ballad; the refrain; burden.
The word 'overword' comes from over- +‎ word.